NGF Upregulates the Plasminogen Activation Inhibitor-1 in Neurons via the Calcineurin/NFAT Pathway and the Down Syndrome-Related Proteins DYRK1A and RCAN1 Attenuate This Effect

Open Access

Peer-reviewed

Research Article

Georgios C. Stefos ,

* E-mail: stegi121@yahoo.gr

Affiliations Institute of Pharmacology and Toxicology, Medical Faculty of the RWTH Aachen University, Aachen, Germany, Systems Biology Programme, Center for Genomic Regulation; Pompeu Fabra University, and Centro de Investigación Biomédica en Red de Enfermedades Raras, Barcelona, Spain
⨯
Ulf Soppa,

Affiliation Institute of Pharmacology and Toxicology, Medical Faculty of the RWTH Aachen University, Aachen, Germany
⨯
Mara Dierssen,

Affiliation Systems Biology Programme, Center for Genomic Regulation; Pompeu Fabra University, and Centro de Investigación Biomédica en Red de Enfermedades Raras, Barcelona, Spain
⨯
Walter Becker

Affiliation Institute of Pharmacology and Toxicology, Medical Faculty of the RWTH Aachen University, Aachen, Germany
⨯

x

Viewed

Powered by Altmetric

Questions or concerns about usage data? Please let us know.

Print

Hyperexpression techniques
Is the Subject Area "Hyperexpression techniques" applicable to this article?

Thanks for your feedback.
Down syndrome
Is the Subject Area "Down syndrome" applicable to this article?

Thanks for your feedback.
Neurons
Is the Subject Area "Neurons" applicable to this article?

Thanks for your feedback.
Protease inhibitor therapy
Is the Subject Area "Protease inhibitor therapy" applicable to this article?

Thanks for your feedback.
Hippocampus
Is the Subject Area "Hippocampus" applicable to this article?

Thanks for your feedback.
Doxycycline
Is the Subject Area "Doxycycline" applicable to this article?

Thanks for your feedback.
Neuronal differentiation
Is the Subject Area "Neuronal differentiation" applicable to this article?

Thanks for your feedback.
Phosphorylation
Is the Subject Area "Phosphorylation" applicable to this article?

Thanks for your feedback.